IP Verse

Hampton Knowles competitive analysis

Explore patent oppositions filed by Hampton Knowles against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 26, 2026

Patent Number	Title	Applicant	Opposition Date
EP4284796	Crystal Form Of 6-(Cyclopropanecarboxamido)-4-((2-Methoxy-3-(1-Methyl-1H-1,2,4-Triazol-3-Yl)Phenyl)Amino)-N-(Methyl-D3)Pyridazine-3-Carboxamide	BRISTOL MYERS SQUIBB	Jan 16, 2026
EP3592732	Manufacture Of A Crystalline Pharmaceutical Product	ORION	Jan 8, 2026
EP4101372	Flexible High-Density Mapping Catheter Tips And Flexible Ablation Catheter Tips With Onboard High-Density Mapping Electrodes	ST JUDE MEDICAL	Sep 25, 2025
EP3487881	Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 Antagonists	NOVARTIS	May 21, 2025
EP4133426	Machine Learning Driven Chemical Compound Replacement Technology	NOTCO DELAWARE	May 20, 2025
EP4209499	Charged Depth Filtration Of Antigen-Binding Proteins	AMGEN	May 7, 2025
EP3458466	Diagnosis Of Inflammatory Bowel Disease Based On Genes	CEDARS SINAI MEDICAL CENTER	May 6, 2025
EP3506931	Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Apr 30, 2025
EP4172301	Low Diacetyl Yeast	CARLSBERG	Apr 24, 2025
EP3889181	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jan 24, 2025

Discover the latest PTAB cases involving Hampton Knowles, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hampton Knowles with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 26, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
HAMPTON KNOWLES	27	-	-	-
NOVARTIS	6	424	-	21
REGENERON PHARMACEUTICALS	38	94	9	31
SANOFI BIOTECHNOLOGY	-	51	-	-